3 Aug 2010
Found this article on the net, which might be of help?
Dietary medium-chain triglycerides (MCT) may improve insulin-mediated glucose metabolism. To examine this possibility, 10 non-insulin-dependent diabetes mellitus (NIDDM) patients, 4 hypertriglyceridemic, and 6 normotriglyceridemic nondiabetic control subjects were examined with a 5-day cross-over design, in which the short-term metabolic effects of a 40% fat diet containing 77.5% of fat calories as MCT were compared with an isocaloric long-chain triglyceride-containing diet. In diabetic patients, MCT failed to alter fasting serum glucose concentrations but reduced preprandial glycemic excursions by 45% (F = 7.9, P less than 0.01). On MCT, the amount of glucose needed to maintain euglycemia during an intravenous insulin infusion was increased in diabetic subjects by 30%, in hypertriglyceridemic subjects by 30%, and in normotriglyceridemic control subjects by 17%. MCT increased mean +/- SE insulin-mediated glucose disposal (4.52 +/- 0.56 vs. 2.89 +/- 0.21 mg.kg-1.min-1; n = 3, P less than 0.05) but failed to alter basal glucose metabolism or insulin-mediated suppression of hepatic glucose output. Metabolic responses to MCT were observed independent of sulfonylurea therapy or severity of fasting hyperglycemia. No change in fasting serum insulin or triglyceride concentrations were seen with MCT administration. Although MCT increased mean fasting serum beta-hydroxybutyrate levels from 0.10 +/- 0.03 to 0.26 +/- 0.06 mM (P less than 0.05) in normotriglyceridemic nondiabetic subjects, no change was seen in diabetic patients. Thus, MCT-containing diets increased insulin-mediated glucose metabolism in both diabetic patients and nondiabetic subjects. In diabetic subjects, this effect appears to be mediated by increases in insulin-mediated glucose disposal.
- Medium Chain Triglycerides Information for Consumers
- Side Effects of Medium Chain Triglycerides (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
My pharmacist says they can't be compared since ethyl esters are added to help stabilize EPA and DHA, increasing thier respective molecular ...
1 answer • 21 Jan 2010
its also can cause of death ?
1 answer • 7 Sep 2010
I have type 1 diabetes and a week before my period i get extremely high bloos sugars. I am hoping this med will help with reducing this problem
1 answer • 18 Jan 2011
my son is taking insulin for type 1 diabetes and he also has hepetis c. should he be taking remeron for sleeplessness,depression,anxiety?
1 answer • 12 Mar 2012
Diabetes, Type 1 - a new dx type 1 diabetes occured past september after ketoacidosis sent us to er?
... she's been taken off of insulin because her pancreas is still producing insulin.it's a temporary condition called the honeymoon phase.i ...
3 answers • 20 Jan 2013